• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Strides Arcolab Gets USFDA Nod to Sell Cancer Drug in US

      Onco Therapies Ltd, a wholly owned subsidiary of Strides Arcolab, has received the US Food and Drug Administration (USFDA) approval to sell the generic version of cisplatin, an anti-cancer injection, in the US market. Cisplatin is a chemotherapy drug used to treat various types of cancers.

      Strides Arcolab Ltd is a major Indian pharmaceutical company that manufactures a wide range of pharmaceutical products, including softgel capsules, sterile injectables and others. Strides Arcolab said in a statement that it has received the approval to market cisplatin injection in the strength of 1 mg/ml in 50ml and 100ml multiple dose vials. The company also reported that the approval of cisplatin has come at just the right time when the US drug market is facing shortage of the chemotherapy drugs.

      "Cisplatin is part of the oncology portfolio licensed to Pfizer in January 2010 for the US market," Strides Arcolab said in a release. The company also added that it expects to launch the product shortly in the US market. According to the data from the India's largest pharmaceutical intelligence and market research company, the annual sale of generic cisplatin in the US is 10 million USD.


      Share this Article!

    Back to top^